Macromolecular biosynthesis inhibitor
Inhibition of bacterial, protozoal and fungal macromolecular biosynthesis
- Inhibits DNA, RNA, phospholipid and protein synthesis at once
- Broad antiprotozoal/antifungal action with ill-defined targets
- Nephrotoxicity and dysglycemia limit use
- Inhibits DNA, RNA, phospholipid and protein synthesis in bacteria, protozoa and fungi
- ⚑ The molecular targets are not well defined
Drugs with this mechanism (1)
- Pentamidine — Antiprotozoal alternative for Pneumocystis pneumonia; parenteral toxicity is formidable.
All mechanisms · Open Macromolecular biosynthesis inhibitor in the interactive console ↗